肝細胞癌に対する治療戦略

概要

論文の詳細を見る
We analyzed the prognosis of the patients who received radiofrequency ablation (RFA) therapy at our hospital, and tried to establish our treatment-strategy for hepatocellular carcinoma (HCC). The subjects were 180 HCC patients. The 5 years survival rate was 70% for the 90 naive cases who matched the Milan criteria. The prognosis was clearly different in 3 groups classified according to the category combining tumor number and tumor size. As a result, the Milan criteria were useful for RFA indication and among them the best candidate was HCCs solitary and less than 3 cm in diameter. Furthermore, HCCs less than 3 cm in diameter and more than 4 in number were also indicative if they were defined as multi-centric development. In conclusion, there is a possibility that the indication of RFA for HCC is wider than the Milan criteria.
特定非営利活動法人 Microwave Surgery研究会の論文